Literature DB >> 6062296

Metabolic pathway of cytostatic dibromohexitols.

L Institóris, I P Horváth, G Pethes, S Eckhardt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6062296

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  4 in total

Review 1.  New drugs under clinical evaluation in the United States.

Authors:  S K Carter
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

2.  Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high grade astrocytoma.

Authors:  T E Elliott; R P Dinapoli; J R O'Fallon; J E Krook; J D Earle; R F Morton; R Levitt; L K Tschetter; B W Scheithauer; D M Pfeifle; D I Twito; R A Nelimark
Journal:  J Neurooncol       Date:  1997-07       Impact factor: 4.130

3.  [Correlation of the differences of biological effects and distribution parameters of 1,6-dibromohexitols].

Authors:  L Institóris; E Dzurillay; J H Sebestyén; A Jeney; G Pethes
Journal:  Z Krebsforsch       Date:  1971

4.  Comparative studies on the in vivo distribution pattern of dibromodulcitol and diepoxydulcitol.

Authors:  G Pethes
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1973
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.